The principal mission of the Duke Center for AIDS Research (CFAR) is to establish and support an academic environment that promotes and encourages the intramural collaboration and coordination of all AIDS-related research activities at Duke, thus serving the requirements of all AIDS investigators and their research programs. This new CFAR application is structured around the establishment of a series of critical Core facilities designed to serve the scientific needs of the basic and clinical AIDS research community and thus facilitate rapid progress in the prevention and treatment of HIV infection. The Delopmental Core will support an annual program for funding innovative pilot research projects as well as a separate funding program for fast-breaking HIV-related research. Additionally, the Developmental Core will initiate a faculty recruitment program in partnership with the Duke University School of Medicine as well as several clinical and basic science Departments. The Flow Cytometry Core will provide state-of-the-art phenotypic and functional analyses of HIV-infected and uninfected samples as well as the only BSL-3 facility on campus capable of high speed sorting of cellular subpopulations from HIV-infected samples. The Molecular Virology Core will provide virologic reagents (i.e., plasmids, vectors, and RNAi) as well as critical virologic services such as viral quantitation, isolation, cloning, sequencing and propagation to meet the needs of the Duke AIDS research community. The Bioinformatics and Biostatistical Core will provide dedicated modeling and statistical support for all basic and clinical investigators. Finally, the Clinical Core will provide access to domestic as well as international patient-related materials and training in order to enhance the focus on insightful clinical AIDS research with specific emphasis on issues critical to Global Health. The CFAR mission will be ensured through the activities of a permanent External Advisory Board, a comprehensive outcomes assessment plan and an effective strategic planning process.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI064518-03
Application #
7279316
Study Section
Special Emphasis Panel (ZAI1-LW-A (J1))
Program Officer
Namkung, Ann S
Project Start
2005-07-01
Project End
2010-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
3
Fiscal Year
2007
Total Cost
$1,514,085
Indirect Cost
Name
Duke University
Department
Surgery
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Watt, Melissa H; Cichowitz, Cody; Kisigo, Godfrey et al. (2018) Predictors of postpartum HIV care engagement for women enrolled in prevention of mother-to-child transmission (PMTCT) programs in Tanzania. AIDS Care :1-12
Itell, Hannah L; McGuire, Erin P; Muresan, Petronella et al. (2018) Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines. Vaccine 36:5600-5608
Wiehe, Kevin; Bradley, Todd; Meyerhoff, R Ryan et al. (2018) Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development. Cell Host Microbe 23:759-765.e6
McGuire, Erin P; Fong, Youyi; Toote, Christopher et al. (2018) HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine. J Virol 92:
Skalski, Linda M; Towe, Sheri L; Sikkema, Kathleen J et al. (2018) Memory Impairment in HIV-Infected Individuals with Early and Late Initiation of Regular Marijuana Use. AIDS Behav 22:1596-1605
Mitchell, John T; LeGrand, Sara; Hightow-Weidman, Lisa B et al. (2018) Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial. JMIR Mhealth Uhealth 6:e10456
Okeke, Nwora Lance; Alenezi, Fawaz; Bloomfield, Gerald S et al. (2018) Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical Cohort. J Card Fail 24:496-503
Clement, Meredith E; Seidelman, Jessica; Wu, Jiewei et al. (2018) An educational initiative in response to identified PrEP prescribing needs among PCPs in the Southern U.S. AIDS Care 30:650-655
Price, Alexander M; Messinger, Joshua E; Luftig, Micah A (2018) c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection. J Virol 92:
Knettel, Brandon A; Cichowitz, Cody; Ngocho, James Samwel et al. (2018) Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa. J Acquir Immune Defic Syndr 77:427-438

Showing the most recent 10 out of 488 publications